Heart Medical (06609) joins hands with Simaide Medical and Aisi Technology to reach a strategic cooperation to jointly build medical AI.
Heart Medical (06609) has joined hands with Simaide Medical and Aisi Technology to reach a strategic cooperation to jointly build medical AI.
On November 10, Shanghai HeartCare Medical Technology Co., Ltd. (hereinafter referred to as "HeartCare Medical"), together with its wholly-owned subsidiary Nanjing Simaide Medical Technology Co., Ltd. (hereinafter referred to as "Simaide Medical"), held a strategic cooperation signing ceremony with Nanjing Aisi Artificial Intelligence Technology Co., Ltd. (hereinafter referred to as "Aisi Technology") in Nanjing Jiangbei New Area.
Following the signing ceremony, the MedAgnes Medical Intelligence Ark large model co-construction project was officially launched, marking that the cooperation between the two parties has further advanced from enterprise-level application exploration to the co-construction and scenario implementation of large models in the medical device industry. Taking this project as an opportunity, the two parties will carry out in-depth cooperation in areas such as large models for the medical device industry, role-based intelligent agents, and intelligent R&D and testing, promoting the integration of artificial intelligence technology with the entire chain of the medical device industry.
The two parties had previously cooperated on enterprise-level intelligent agent applications. Based on AgnesHarness, Aisi Technology has customized and delivered a dedicated office platform for HeartCare Medical (06609), integrating five types of role-based intelligent agents and supporting permission management capabilities. The platform can flexibly configure model, tool, and data permissions according to the enterprise's organizational structure and business needs, enabling customized delivery from application development to deployment management, while balancing business adaptability with security and controllability.
This cooperation will build on existing application practices to further expand the application of AI in the medical device industry. Using the MedAgnes Medical Intelligence Ark large model as the carrier, and focusing on professional knowledge in the medical device industry, enterprise business processes, and R&D testing scenarios, the two parties will gradually build industry solutions covering professional models, intelligent agent applications, and device collaboration.
Related Articles

HK Stock Market Move | BeOne Medicines Ltd. (06160) rose more than 3% in morning trading; raised full-year revenue guidance three times this year; innovative pipeline about to enter a realization phase.

Optimizing structure, confirming rights via offer, calibrating circulation: Is CONTEL (01912) up over 260% for the year just the beginning?

China Galaxy Securities: Performance diverges across chemical sub-sectors; recommend focusing on related cyclical elasticity investment opportunities.
HK Stock Market Move | BeOne Medicines Ltd. (06160) rose more than 3% in morning trading; raised full-year revenue guidance three times this year; innovative pipeline about to enter a realization phase.

Optimizing structure, confirming rights via offer, calibrating circulation: Is CONTEL (01912) up over 260% for the year just the beginning?

China Galaxy Securities: Performance diverges across chemical sub-sectors; recommend focusing on related cyclical elasticity investment opportunities.






